These results demonstrated the abnormal accumulations of Aβ and Tau in the hippocampus and cerebral cortex of STZ-treated 3×Tg-AD mice, and what is more SG-Tang treatment could reduce these important AD phenotypes. This evidence concerns the gene MAPT and Alzheimer disease.